Hong Kong Pharma Digital Technology Holdings Ltd
Research Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) on Bullrun: market cap USD 2.63M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHKPD
- ExchangeNASDAQ
- CountryHong Kong
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Market capUSD 2.63M
- Financial periodFY2026
- RevenueUSD 13.43M
- Revenue growth-33.9%
- Net income-USD 1.14M
- Free cash flow-USD 794.15K
- Gross margin10.3%
Valuation Snapshot
latest market cap is USD 2.63M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 13.43M | -USD 1.14M | -USD 794.15K | 10.3% | n/a | USD 221.84K | USD 1.26M | USD 9.58M |
| FY2025 | USD 20.31M | -USD 27.06K | USD 414.23K | 11.9% | 0 | USD 748.72K | USD 2.37M | USD 4.99M |
| FY2024 | USD 16.69M | USD 1.33M | -USD 482.35K | 21.3% | 0.12 | USD 619.58K | USD 2.09M | USD 4.25M |
| FY2023 | USD 12.56M | USD 998.20K | USD 1.61M | 21.8% | 0.09 | USD 524.61K | USD 691.08K | USD 585.24K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 2.63M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.02M | n/a | n/a | n/a |
About Hong Kong Pharma Digital Technology Holdings Ltd
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hong Kong Pharma Digital Technology Holdings Ltd's market cap?
Hong Kong Pharma Digital Technology Holdings Ltd's market capitalization is USD 2.63M.
What does Hong Kong Pharma Digital Technology Holdings Ltd do?
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products.